AMERICAN CENTURY COMPANIES INC - BLUEBIRD BIO INC ownership

BLUEBIRD BIO INC's ticker is BLUE and the CUSIP is 09609G100. A total of 211 filers reported holding BLUEBIRD BIO INC in Q4 2016. The put-call ratio across all filers is 0.81 and the average weighting 0.1%.

Quarter-by-quarter ownership
AMERICAN CENTURY COMPANIES INC ownership history of BLUEBIRD BIO INC
ValueSharesWeighting
Q4 2023$137,739
+2.3%
99,811
+125.4%
0.00%
Q3 2023$134,605
+34.1%
44,278
+45.1%
0.00%
Q2 2023$100,388
+116.1%
30,513
+106.3%
0.00%
Q1 2023$46,450
-67.2%
14,793
-27.8%
0.00%
Q4 2022$141,825
-98.5%
20,495
-88.4%
0.00%
-100.0%
Q3 2020$9,506,000
-11.5%
176,200
+0.1%
0.01%
-20.0%
Q2 2020$10,745,000
+32.9%
176,038
+0.1%
0.01%0.0%
Q1 2020$8,087,000
-81.6%
175,948
-64.8%
0.01%
-76.2%
Q4 2019$43,889,000
+3.3%
500,155
+8.1%
0.04%
-2.3%
Q3 2019$42,468,000
-36.1%
462,513
-11.5%
0.04%
-34.8%
Q2 2019$66,496,000
-12.4%
522,765
+8.3%
0.07%
-14.3%
Q1 2019$75,951,000
+68.5%
482,751
+6.3%
0.08%
+51.0%
Q4 2018$45,067,000
-4.2%
454,308
+41.1%
0.05%
+10.9%
Q3 2018$47,024,000
+55.8%
322,080
+67.5%
0.05%
+53.3%
Q2 2018$30,186,000
-8.6%
192,331
-0.6%
0.03%
-11.8%
Q1 2018$33,031,000
-20.8%
193,447
-17.4%
0.03%
-19.0%
Q4 2017$41,715,000
+33.8%
234,220
+3.2%
0.04%
+31.2%
Q3 2017$31,170,000
+4078.3%
226,935
+1778.0%
0.03%
+3100.0%
Q4 2016$746,000
-39.9%
12,084
-34.0%
0.00%0.0%
Q3 2016$1,242,000
+368.7%
18,321
+344.1%
0.00%
Q4 2015$265,000
-97.7%
4,125
-97.0%
0.00%
-100.0%
Q3 2015$11,591,000
-46.0%
135,493
+6.2%
0.01%
-41.7%
Q2 2015$21,477,000
+888.4%
127,561
+609.0%
0.02%
+1100.0%
Q1 2015$2,173,000
+26.7%
17,992
-3.8%
0.00%0.0%
Q4 2014$1,715,00018,6930.00%
Other shareholders
BLUEBIRD BIO INC shareholders Q4 2016
NameSharesValueWeighting ↓
Casdin Capital, LLC 82,500$5,090,0004.20%
RTW INVESTMENTS, LP 122,576$7,563,0002.85%
Eventide Asset Management 587,677$36,260,0002.36%
First Light Asset Management, LLC 71,246$4,396,0001.93%
ARK Investment Management 75,645$4,667,0001.70%
Taylor Wealth Management Partners 39,118$2,414,0001.12%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 302,027$18,635,0000.77%
ARMISTICE CAPITAL, LLC 40,000$2,468,0000.58%
Artal Group S.A. 422,536$26,070,0000.58%
TURNER INVESTMENTS LLC 21,020$1,297,0000.52%
View complete list of BLUEBIRD BIO INC shareholders